GR3007026T3 - - Google Patents

Info

Publication number
GR3007026T3
GR3007026T3 GR920402458T GR920402458T GR3007026T3 GR 3007026 T3 GR3007026 T3 GR 3007026T3 GR 920402458 T GR920402458 T GR 920402458T GR 920402458 T GR920402458 T GR 920402458T GR 3007026 T3 GR3007026 T3 GR 3007026T3
Authority
GR
Greece
Prior art keywords
acetyl
grams
carnitine
bolus
dramatically
Prior art date
Application number
GR920402458T
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3007026T3 publication Critical patent/GR3007026T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
GR920402458T 1985-10-14 1993-02-11 GR3007026T3 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT48663/85A IT1184655B (it) 1985-10-14 1985-10-14 Imiego di acetil l-carnitina nel trattamento terapeutico degli stati di shock

Publications (1)

Publication Number Publication Date
GR3007026T3 true GR3007026T3 (el) 1993-07-30

Family

ID=11267907

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920402458T GR3007026T3 (el) 1985-10-14 1993-02-11

Country Status (8)

Country Link
US (1) US4771075A (el)
EP (1) EP0225856B1 (el)
JP (1) JPH0780765B2 (el)
AT (1) ATE85521T1 (el)
DE (1) DE3687742T2 (el)
ES (1) ES2043608T3 (el)
GR (1) GR3007026T3 (el)
IT (1) IT1184655B (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1235153B (it) * 1988-11-15 1992-06-22 Sigma Tau Ind Farmaceuti Uso dell'acetil l-carnitina nel trattamento terapeutico della cataratta e composizioni farmaceutiche utili in tale trattamento
IT1244636B (it) * 1991-01-04 1994-08-08 Sigma Tau Ind Farmaceuti Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento.
US5668117A (en) * 1991-02-22 1997-09-16 Shapiro; Howard K. Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments
IT1254331B (it) * 1992-04-23 1995-09-14 Sigma Tau Ind Farmaceuti Composizione farmaceutica per il trattamento dello shock, particolarmente dello shock cardiogeno e dello shock settico.
IT1263004B (it) * 1992-10-08 1996-07-23 Sigma Tau Ind Farmaceuti Impiego della l-carnitina e acil l-carnitine nel trattamento a lungo termine di pazienti diabetici non insulino-dipendenti.
IT1261828B (it) * 1993-07-14 1996-06-03 Sigma Tau Ind Farmaceuti Esteri di acil l-carnitine e composizioni farmaceutiche che li contengono per il trattamento dello shock endotossico.
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1156769B (it) * 1978-05-25 1987-02-04 Sigma Tau Ind Farmaceuti Applicazione terapeutica della carnitina e di altri acil derivati della carnitina
US4346107A (en) * 1979-02-12 1982-08-24 Claudio Cavazza Pharmaceutical composition comprising acyl-carnitine for the treatment of impaired cerebral metabolism
IT1142934B (it) * 1981-11-06 1986-10-15 Sigma Tau Ind Farmaceuti Uso della carnitina e delle acilcarnitine inferiori nel trattamento terapeutico della patologia delle vene
CH655005A5 (it) * 1983-02-16 1986-03-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica ad azione metabolica ed energetica utilizzabile in terapia cardiaca e vascolare.

Also Published As

Publication number Publication date
DE3687742T2 (de) 1993-05-27
EP0225856A3 (en) 1989-06-07
IT8548663A0 (it) 1985-10-14
IT1184655B (it) 1987-10-28
US4771075A (en) 1988-09-13
ATE85521T1 (de) 1993-02-15
JPS6296423A (ja) 1987-05-02
EP0225856A2 (en) 1987-06-16
JPH0780765B2 (ja) 1995-08-30
DE3687742D1 (de) 1993-03-25
EP0225856B1 (en) 1993-02-10
ES2043608T3 (es) 1994-01-01

Similar Documents

Publication Publication Date Title
IL81444A (en) Pressure regulated implantable infusion pump
ZA867386B (en) Pharmaceutical and dietary composition
EP0364293A3 (en) Blood pumping catheter
DE58900340D1 (de) Medizinischer katheter fuer die intravaskulaere langzeitinfusion von medikamenten.
EP0217964A4 (en) MEDICAL PUMP ARRANGEMENT.
IE850309L (en) Infusion system
ES8306026A1 (es) "perfeccionamientos introducidos en los dispositivos para la depuracion de productos metabolicos en la sangre".
AU2807389A (en) Inflow cannula for intravascular blood pumps
GR3007026T3 (el)
JPS56104815A (en) Remedy for peripheral orthostatic hypotension
USD285347S (en) Rotary peristaltic pump for intravenous delivery of medical solutions to patients
IE822064L (en) Composition containing human insulin and c-peptide
GB2224444B (en) Syringe infusion pump
Shanks et al. Stimulation of adrenergic beta-receptors by orciprenaline.
AU5065585A (en) Continuous intravenous infusion of adenosine to human patients, a unit dosage form of adenosine and use of adenosine for the manufacture of medicaments
IT1254331B (it) Composizione farmaceutica per il trattamento dello shock, particolarmente dello shock cardiogeno e dello shock settico.
EP0193164A3 (en) Sustained-release pharmaceutical preparation which comprised 2-nitroxy-methyl-6-chloropyridine, process for its preparation and use thereof
EP0263174A4 (en) INCREASED VESSEL PERFUSION AFTER ADMINISTRATION OF LIPIDS.
USD323030S (en) Medical syringe for administering subcutaneous injections
EP0369997A3 (en) An intravenous administration infusor
EP0232697A3 (en) Pharmaceutical compositions containing acth fragments for the therapy of shock conditions and of respiratory and cardiocirculatory insufficiencies
ES8800665A1 (es) Un procedimiento para la preparacion de nuevos derivados de prostaglandina.
EP0340933A3 (en) Heparin-containing formulations
CA2160689A1 (en) New Method of Treatment
SE9303787L (sv) Läkemedel för infusionsbehandling